| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |